Insights into the elimination of vivax malaria in China  

作　　者：Fang Huang Li Zhang Zhi-Gui Xia 

机构地区：[1]Shanghai Municipal Center for Disease Control and Prevention,Shanghai,200336,China [2]National Institute of Parasitic Diseases,Chinese Center for Disease Control and Prevention(Chinese Center for Tropical Diseases Research),NHC Key Laboratory of Parasite and Vector Biology,WHO Collaborating Center for Tropical Diseases,National Center for International Research on Tropical Diseases,Shanghai,200025,China

出　　处：《Infectious Diseases of Poverty》2023年第2期101-105,共5页贫困所致传染病（英文）

基　　金：supported by the National Malaria Elimination Program of China and the Natural Science Foundation of Shanghai(No.18ZR1443400).

摘　　要：Background Malaria is caused by multiple parasitic species of the genus Plasmodium.Plasmodium vivax is the most geographically widespread and poses challenges in elimination due to its unique biological and epidemiological characteristics.The aim of study was to highlight the practices and experience targeting vivax malaria control and elimination in China.Main body P.vivax malaria was historically endemic in more than 70%of counties in China,with reported vivax malaria cases as high as 26 million a year.After around 70 years of effort,China was certified as malaria-free in June of 2021.The key insights into China’s vivax malaria control and elimination were offered,including radical cure strategies,comprehensive but adaptive strategies targeting species of Plasmodium and Anopheles,mass drug administration,and case-/focus-centred surveillance and response systems.Conclusion The complete global eradication of P.vivax and eventually malaria will be more difficult,and China’s practices and experience could be a valuable reference in this campaign.

关 键 词：MALARIA Plasmodium vivax ELIMINATION China 

分 类 号：R531.3[医药卫生—内科学] R181.3[医药卫生—临床医学]